Ultragenyx Pharmaceutical Inc.

ROYAL BANK OF CANADA RARE

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

163,227

Value ($000)

3,754

Weight

0.0%

2019 Q4 - 2025 Q4 (24 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	3,754	0.0%	163,227	12/31/2025
2025 Q2	8/14/2025	365	0.0%	10,043	6/30/2025
2025 Q1	11/21/2025	209	0.0%	5,790	3/31/2025
2024 Q4	2/14/2025	2,934	0.0%	69,742	12/31/2024
2024 Q3	11/14/2024	3,674	0.0%	66,130	9/30/2024
2024 Q2	11/6/2024	191	0.0%	4,678	6/30/2024
2024 Q1	11/5/2024	317	0.0%	6,798	3/31/2024
2023 Q4	2/14/2024	1,590	0.0%	33,247	12/31/2023
2023 Q3	11/14/2023	1,273	0.0%	35,749	9/30/2023
2023 Q2	8/14/2023	2,618	0.0%	56,735	6/30/2023
2023 Q1	5/15/2023	2,277	0.0%	56,778	3/31/2023
2022 Q4	2/14/2023	197	0.0%	4,250	12/31/2022
2022 Q3	11/14/2022	155	0.0%	3,760	9/30/2022
2022 Q2	8/15/2022	410	0.0%	6,852	6/30/2022
2022 Q1	5/16/2022	526	0.0%	7,251	3/31/2022
2021 Q4	2/14/2022	734	0.0%	8,727	12/31/2021
2021 Q3	11/15/2021	719	0.0%	7,988	9/30/2021
2021 Q2	8/16/2021	3,052	0.0%	32,006	6/30/2021
2021 Q1	7/20/2021	727	0.0%	6,379	3/31/2021
2020 Q4	2/16/2021	686	0.0%	4,961	12/31/2020
2020 Q3	11/16/2020	194	0.0%	2,365	9/30/2020
2020 Q2	8/14/2020	95	0.0%	1,209	6/30/2020
2020 Q1	6/16/2020	8	0.0%	173	3/31/2020
2019 Q4	2/14/2020	107	0.0%	2,531	12/31/2019